Global Pharma Ophthalmic Market Research Report 2012-2024

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

1.1.2 Specifications

1.2 Market Segment

1.2.1 by Type

1.2.1.1 Retinal disorders drugs 

1.2.1.2 Allergic, inflammatory and infective drugs 

1.2.1.3 Glaucoma drugs 

1.2.1.4 Dry eye drugs 

1.2.1.5 Other ophthalmic drugs

1.2.2 by Application

1.2.2.1 Glaucoma 

1.2.2.2 Dry eye syndrome 

1.2.2.3 Retinal diseases 

1.2.2.4 Other ophthalmic indications

1.2.3 by Regions

2 Industry Chain

2.1 Industry Chain Structure

2.2 Upstream

2.3 Market

2.3.1 SWOT

2.3.2 Dynamics

3 Environmental Analysis

3.1 Policy

3.2 Economic

3.3 Technology

3.4 Market Entry

4 Market Segmentation by Type

4.1 Market Size

4.1.1 Retinal disorders drugs  Market, 2013-2018

4.1.2 Allergic, inflammatory and infective drugs  Market, 2013-2018

4.1.3 Glaucoma drugs  Market, 2013-2018

4.1.4 Dry eye drugs  Market, 2013-2018

4.1.5 Other ophthalmic drugs Market, 2013-2018

4.2 Market Forecast

4.2.1 Retinal disorders drugs  Market Forecast, 2019-2024

4.2.2 Allergic, inflammatory and infective drugs  Market Forecast, 2019-2024

4.2.3 Glaucoma drugs  Market Forecast, 2019-2024

4.2.4 Dry eye drugs  Market Forecast, 2019-2024

4.2.5 Other ophthalmic drugs Market Forecast, 2019-2024

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Glaucoma  Market, 2013-2018

5.1.2 Dry eye syndrome  Market, 2013-2018

5.1.3 Retinal diseases  Market, 2013-2018

5.1.4 Other ophthalmic indications Market, 2013-2018

5.2 Market Forecast

5.2.1 Glaucoma  Market Forecast, 2019-2024

5.2.2 Dry eye syndrome  Market Forecast, 2019-2024

5.2.3 Retinal diseases  Market Forecast, 2019-2024

5.2.4 Other ophthalmic indications Market Forecast, 2019-2024

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2012-2018

6.1.1.2 Asia-Pacific Market by Type

6.1.1.3 Asia-Pacific Market by Application

6.1.2 North America

6.1.2.1 North America Market, 2012-2018

6.1.2.2 North America Market by Type

6.1.2.3 North America Market by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2012-2018

6.1.3.2 Europe Market by Type

6.1.3.3 Europe Market by Application

6.1.4 South America

6.1.4.1 South America Market, 2012-2018

6.1.4.2 South America Market by Type

6.1.4.3 South America Market by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2012-2018

6.1.5.2 Middle East & Africa Market by Type

6.1.5.3 Middle East & Africa Market by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2019-2024

6.2.2 North America Market Forecast, 2019-2024

6.2.3 Europe Market Forecast, 2019-2024

6.2.4 South America Market Forecast, 2019-2024

6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

7.1 Global Market by Vendors

7.2 Market Concentration

7.3 Price & Factors

7.4 Marketing Channel

8 Major Vendors

8.1 Novartis 

8.2 Allergan 

8.3 Roche 

8.4 Valeant 

8.5 Regeneron 

8.6 Santen 

8.7 Bayer 

8.8 Pfizer 

8.9 Senju 

8.10 Akorn

9 Conclusion

Table Products Segment of Pharma Ophthalmic

Table Retinal disorders drugs  Overview

Table Allergic, inflammatory and infective drugs  Overview

Table Glaucoma drugs  Overview

Table Dry eye drugs  Overview

Table Other ophthalmic drugs Overview

Table Global Pharma Ophthalmic Market by Type, 2011-2022 (USD Million)

Table Application Segment of Pharma Ophthalmic

Table Glaucoma  Overview

Table Dry eye syndrome  Overview

Table Retinal diseases  Overview

Table Other ophthalmic indications Overview

Table Global Pharma Ophthalmic Market by Application, 2011-2022 (USD Million)

Table Global Pharma Ophthalmic Market by Region, 2011-2022 (USD Million)

Table Cost of Pharma Ophthalmic

Table Market Dynamics

Table Policy of Pharma Ophthalmic

Table GDP of Major Countries

Table Retinal disorders drugs  CAGR by Revenue and Volume, 2012-2018

Table Allergic, inflammatory and infective drugs  CAGR by Revenue and Volume, 2012-2018

Table Glaucoma drugs  CAGR by Revenue and Volume, 2012-2018

Table Dry eye drugs  CAGR by Revenue and Volume, 2012-2018

Table Other ophthalmic drugs CAGR by Revenue and Volume, 2012-2018

Table Retinal disorders drugs  CAGR by Revenue and Volume, 2012-2024

Table Allergic, inflammatory and infective drugs  CAGR by Revenue and Volume, 2012-2024

Table Glaucoma drugs  CAGR by Revenue and Volume, 2012-2024

Table Dry eye drugs  CAGR by Revenue and Volume, 2012-2024

Table Other ophthalmic drugs CAGR by Revenue and Volume, 2012-2024

Table Glaucoma  CAGR by Revenue and Volume, 2012-2018

Table Dry eye syndrome  CAGR by Revenue and Volume, 2012-2018

Table Retinal diseases  CAGR by Revenue and Volume, 2012-2018

Table Other ophthalmic indications CAGR by Revenue and Volume, 2012-2018

Table Global Pharma Ophthalmic Market by Vendors, 2012-2018 (USD Million)

Table Global Pharma Ophthalmic Market by Vendors, 2012-2018 (in Volume)

Table Global Pharma Ophthalmic Market Share by Vendors, 2012-2018 (USD Million)

Table Global Pharma Ophthalmic Market Share by Vendors, 2012-2018 (in Volume)

Table Price Factors List

Table Novartis  Profile List

Table Microecological Modulator Operating Data of Novartis  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Allergan  Profile List

Table Microecological Modulator Operating Data of Allergan  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche  Profile List

Table Microecological Modulator Operating Data of Roche  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Valeant  Profile List

Table Microecological Modulator Operating Data of Valeant  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Regeneron  Profile List

Table Microecological Modulator Operating Data of Regeneron  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Santen  Profile List

Table Microecological Modulator Operating Data of Santen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer  Profile List

Table Microecological Modulator Operating Data of Bayer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer  Profile List

Table Microecological Modulator Operating Data of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Senju  Profile List

Table Microecological Modulator Operating Data of Senju  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Akorn Profile List

Table Microecological Modulator Operating Data of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)